logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11129900 B1

PDFFull Text
Date of Patent:
Sep. 28, 2021

Filed:

Dec. 25, 2015

Cytophilic peptide-fused high-density lipoprotein, and delivery of drug to posterior segment of eye by ocular installation of said fusion

Applicants:

Kyoto University, Kyoto, JP;

Nosta Ag, Basel, CH;

Inventors:

Kenji Suda, Kyoto, JP;

Tatsuya Murakami, Toyama, JP;

Nagahisa Yoshimura, Osaka, JP;

Norimoto Gotoh, Fujinomiya, JP;

Assignees:

KYOTO UNIVERSITY, Kyoto, JP;

NOSTA AG, Basel, CH;

Attorney:

Wenderoth, Lind & Ponack, L.L.P.

Primary Examiner:

Zachary C Howard

Int. Cl.
CPC ...
A61K 47/64 (2017.01); A61K 47/69 (2017.01); C07K 14/775 (2006.01); A61P 21/02 (2006.01); A61K 45/00 (2006.01); A61K 47/42 (2017.01); C07K 19/00 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); A61P 9/10 (2006.01); A61P 27/02 (2006.01); A61P 27/06 (2006.01); A61P 27/12 (2006.01); A61P 27/10 (2006.01); A61K 9/00 (2006.01); A61K 47/24 (2006.01); A61K 31/506 (2006.01);
U.S. Cl.
CPC ...
A61K 47/64 (2017.08); A61K 9/0048 (2013.01); A61K 45/00 (2013.01); A61K 47/42 (2013.01); A61K 47/6455 (2017.08); A61K 47/6917 (2017.08); A61P 9/10 (2018.01); A61P 27/02 (2018.01); A61P 27/06 (2018.01); A61P 27/10 (2018.01); A61P 27/12 (2018.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/775 (2013.01); C07K 19/00 (2013.01); A61K 31/506 (2013.01); A61K 47/24 (2013.01); C07K 2319/01 (2013.01);
Abstract

The purpose of the present invention is to provide a novel system for the delivery of a drug to a posterior segment of the eye. The present invention relates to: a cytophilic peptide-fused high-density lipoprotein (cHDL) which can be used as a carrier for the delivery of a drug to a posterior segment of the eye; a method for producing the cytophilic peptide-fused high-density lipoprotein; a system of the delivery of a drug to a posterior segment of the eye, a pharmaceutical composition, and a system of the delivery of a drug to a posterior segment of the eye, each of which utilizes the cytophilic peptide-fused high-density lipoprotein; and a method for diagnosing, preventing or treating posterior ocular disease.

Find Patent Forward Citations

Suda, Kenji. (2021). Cytophilic peptide-fused high-density lipoprotein, and delivery of drug to posterior segment of eye by ocular installation of said fusion (U.S. Patent No. 11129900). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11129900

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…